No Data
US Stock MarketDetailed Quotes
GDRX GoodRx
Watchlist
5.970
+0.030+0.51% Close 12/08 16:00 ET
5.9700.0000.00%
Post 16:13 ET
5.990High5.860Low787.78KVolume
5.890Open5.940Pre Close4.68MTurnover1.05%Turnover Ratio199.00P/E (TTM)2.42BMarket Cap9.37052wk HighLossP/E (Static)406.13MShares4.13552wk Low2.75P/B446.40MFloat Cap64.219Historical High--Dividend TTM74.77MShs Float3.820Historical Low--Div YieldTTM2.19%Amplitude5.938Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About GoodRx Company
GoodRx Holdings, Inc. engages in the business of a consumer-focused digital healthcare platform. The firm offers consumers free access to transparent and lower prices for brand and generic medications, affordable and convenient medical provider consultations via telehealth, and comprehensive healthcare research and information. The company was founded by Trevor Bezdek and Douglas Joseph Hirsch in September 2015 and is headquartered in Santa Monica, CA.
Revenue Breakdown
Business
Currency:USD
2022/12/31
Stock NameRevenueRatio
Prescription transactions revenue550.54M71.82%
Pharma manufacturer solutions revenue99.43M12.97%
Subscription revenue96.17M12.55%
Other revenue20.43M2.66%
News
GoodRx Says 'Currently, GoodRx Hosts Discount Card Pricing Agreements Informed by Acquisition Cost-based Pricing at a Number of Key Retail Pharmacy Partners, Including CVS Pharmacy'
GoodRx Says 'Currently, GoodRx Hosts Discount Card Pricing Agreements Informed by Acquisition Cost-based Pricing at a Number of Key Retail Pharmacy Partners, Including CVS Pharmacy'
GoodRX Says Co Is 'Well Positioned in a Market With Evolving Pharmacy Reimbursement Models That Bring Greater Transparency to Prescription Drug Costs'
GoodRX Says Co Is 'Well Positioned in a Market With Evolving Pharmacy Reimbursement Models That Bring Greater Transparency to Prescription Drug Costs'
GoodRx Falls after CVS Annouces Affordable Drug Program
fell Tuesday after raising 13% last week. The drop followed
Comments
ColumnsGoodRx Falls after CVS Annouces Affordable Drug Program
$GoodRx(GDRX.US$ fell Tuesday after raising 13% last week. The drop followed $CVS Health(CVS.US$ investor day. The firm relased 2024 revenue guidance Tuesday morning, announcing a competitive prescription drug product called CostVantage, and a second program called TrueCost.
1
Buying Opportunity
Stock is near 52 week low. large block purchases are being made on this dip still might have room to be lower. going to take position on the stock due to revenue and brand name. if there is any kind of recession in the near future the stock will be back up to its high due to individuals looking for the best options to pay for their prescriptions.
good luck investing 😸
good luck investing 😸
GoodRx's diminishing returns, despite reinvestment, is disheartening. Its sharp stock price drop could indicate investor anticipation of worsening company fundamentals, suggesting other investment options may be more promising.
ColumnsToday's Pre-Market Stock Movers And Top Ratings: CVX, F, ADBE, UPS and More
Pre-Market Stock Movers
Gapping up
$Adobe(ADBE.US$
(The stock gained 2.4% before the bell after Morgan Stanley upgraded shares to overweight from equal weight and boosted its price target, citing artificial intelligence tailwinds.)
$Chevron(CVX.US$
(Shares rose 1.6% after Goldman Sachs upgraded Chevron to buy from neutral and hiked its price target. Analysts said the oil giant is due for a breakout.)
$Disney(DIS.US$
(T...
Gapping up
$Adobe(ADBE.US$
(The stock gained 2.4% before the bell after Morgan Stanley upgraded shares to overweight from equal weight and boosted its price target, citing artificial intelligence tailwinds.)
$Chevron(CVX.US$
(Shares rose 1.6% after Goldman Sachs upgraded Chevron to buy from neutral and hiked its price target. Analysts said the oil giant is due for a breakout.)
$Disney(DIS.US$
(T...
24
$GoodRx(GDRX.US$ BOOOOOOM
1
ColumnsToday's pre-market stock movers: NVAX, MRNA, NCLH, MU and more
Gainers:
In reaction to earnings/guidance:
• $GoodRx(GDRX.US$ +38.5%,$EDGIO(EGIO.US$ +13.5%,$Lemonade(LMND.US$ +10.7%,$Desktop Metal(DM.US$ +8.5%,$ShockWave Medical(SWAV.US$ +8.2%,$Pubmatic(PUBM.US$ +8.1%,$Olaplex(OLPX.US$ +7%,$Vivid Seats(SEAT.US$ +6.4%,$Noble(NE.US$ +6.3%,$Aspen Technology(AZPN.US$ +5.4%,$AAON Inc(AAON.US$ +5%,$Hudbay Minerals(HBM.US$ +5%,$Vivint Smart Home(VVNT.US$ +4.9%,$Vivint Smart Home(VVNT.US$ +4...
In reaction to earnings/guidance:
• $GoodRx(GDRX.US$ +38.5%,$EDGIO(EGIO.US$ +13.5%,$Lemonade(LMND.US$ +10.7%,$Desktop Metal(DM.US$ +8.5%,$ShockWave Medical(SWAV.US$ +8.2%,$Pubmatic(PUBM.US$ +8.1%,$Olaplex(OLPX.US$ +7%,$Vivid Seats(SEAT.US$ +6.4%,$Noble(NE.US$ +6.3%,$Aspen Technology(AZPN.US$ +5.4%,$AAON Inc(AAON.US$ +5%,$Hudbay Minerals(HBM.US$ +5%,$Vivint Smart Home(VVNT.US$ +4.9%,$Vivint Smart Home(VVNT.US$ +4...
21
ColumnsToday's pre-market stock movers: DOCU, BGNE, RBLX, SFIX and more
Gainers:
• $Cogent Biosciences(COGT.US$ +7.9% (announces positive initial clinical data from ongoing phase 2 APEX trial evaluating bezuclastinib in patients with advanced systemic mastocytosis)
• $Univar Solutions(UNVR.US$ +7.2% (expands distribution partnership with BASF)
• $Vail Resorts(MTN.US$ +6% (In reaction to earnings/guidance)
• $BeiGene(BGNE.US$ +5.4% (highlights growing portfolio and pipeline targeting hematologic mali...
• $Cogent Biosciences(COGT.US$ +7.9% (announces positive initial clinical data from ongoing phase 2 APEX trial evaluating bezuclastinib in patients with advanced systemic mastocytosis)
• $Univar Solutions(UNVR.US$ +7.2% (expands distribution partnership with BASF)
• $Vail Resorts(MTN.US$ +6% (In reaction to earnings/guidance)
• $BeiGene(BGNE.US$ +5.4% (highlights growing portfolio and pipeline targeting hematologic mali...
17
7
ColumnsTop upgrades and downgrades on 6/10: NFLX, EBAY, RBLX, EA and more
Upgrades
• $CME Group(CME.US$ : Atlantic Equities Upgrades to Overweight from Neutral - PT $235
• $Spirit Airlines(SAVE.US$ : JPMorgan Upgrades to Overweight from Neutral - PT $30 (from $24)
• $SciPlay(SCPL.US$ : Wedbush Upgrades to Outperform from Neutral - PT $17 (from $14.50)
Downgrades
• $Bilibili(BILI.US$ : ICBC Downgrades to Neutral from Outperform - PT $26.20
• $Blueprint Medicines(BPMC.US$ : Citigroup Downgrades to Se...
• $CME Group(CME.US$ : Atlantic Equities Upgrades to Overweight from Neutral - PT $235
• $Spirit Airlines(SAVE.US$ : JPMorgan Upgrades to Overweight from Neutral - PT $30 (from $24)
• $SciPlay(SCPL.US$ : Wedbush Upgrades to Outperform from Neutral - PT $17 (from $14.50)
Downgrades
• $Bilibili(BILI.US$ : ICBC Downgrades to Neutral from Outperform - PT $26.20
• $Blueprint Medicines(BPMC.US$ : Citigroup Downgrades to Se...
18
ColumnsToday's pre-market stock movers: CRM, WB, LI, NIO and more
Gainers:
• $Victoria's Secret(VSCO.US$ +10.4% (In reaction to earnings)
• $Salesforce(CRM.US$ +9.0% (In reaction to earnings)
• $Navigator(NVGS.US$ +4.9% (names Mads Peter Zacho as CEO)
• $Weibo(WB.US$ +4.7% (In reaction to earnings)
• $CAE Inc(CAE.US$ +4.7% (In reaction to earnings)
• $Laredo Petroleum(LPI.US$ +4% (authorized $200 mln share repurchase program)
• $Axsome Therapeutics(AXSM.US$ +3.1% (Late-Breaking Presentations of P...
• $Victoria's Secret(VSCO.US$ +10.4% (In reaction to earnings)
• $Salesforce(CRM.US$ +9.0% (In reaction to earnings)
• $Navigator(NVGS.US$ +4.9% (names Mads Peter Zacho as CEO)
• $Weibo(WB.US$ +4.7% (In reaction to earnings)
• $CAE Inc(CAE.US$ +4.7% (In reaction to earnings)
• $Laredo Petroleum(LPI.US$ +4% (authorized $200 mln share repurchase program)
• $Axsome Therapeutics(AXSM.US$ +3.1% (Late-Breaking Presentations of P...
21
ColumnsTop upgrades and downgrades on 6/1
Upgrades
• $Blueprint Medicines(BPMC.US$ : Jefferies Upgrades to Buy from Hold - PT $78 (from $88)
• $CatchMark Timber Trust Inc(CTT.US$ : Raymond James Upgrades to Market Perform from Underperform
• $Danaher(DHR.US$ : RBC Capital Upgrades to Outperform from Sector Perform - PT $310 (from $299)
• $Enanta Pharmaceuticals(ENTA.US$ : Evercore ISI Upgrades to In Line from Underperform - PT $39 (from $35)
• $FEMSA(FMX.US$ : Bradesco BBI Upgrades to Outperform f...
• $Blueprint Medicines(BPMC.US$ : Jefferies Upgrades to Buy from Hold - PT $78 (from $88)
• $CatchMark Timber Trust Inc(CTT.US$ : Raymond James Upgrades to Market Perform from Underperform
• $Danaher(DHR.US$ : RBC Capital Upgrades to Outperform from Sector Perform - PT $310 (from $299)
• $Enanta Pharmaceuticals(ENTA.US$ : Evercore ISI Upgrades to In Line from Underperform - PT $39 (from $35)
• $FEMSA(FMX.US$ : Bradesco BBI Upgrades to Outperform f...
10
2
ColumnsToday's pre-market stock movers: PTON, NVAX, AMC, SONY and more
Gainers:
• $Biohaven(BHVN.US$ +70.3% (Biohaven Pharmaceutical and Pfizer (PFE) announce that the companies have entered into a definitive agreement under which Pfizer will acquire Biohaven)
• $Vroom(VRM.US$ +33.3% (also CEO Paul Hennessy steps down; Tom Shortt appointed as CEO)
• $Nuvve(NVVE.US$ +10.2% (NVVE and CENN announce alliance to offer electrification solution for commercial fleets)
• $ShockWave Medical(SWAV.US$ +14.6% (I...
• $Biohaven(BHVN.US$ +70.3% (Biohaven Pharmaceutical and Pfizer (PFE) announce that the companies have entered into a definitive agreement under which Pfizer will acquire Biohaven)
• $Vroom(VRM.US$ +33.3% (also CEO Paul Hennessy steps down; Tom Shortt appointed as CEO)
• $Nuvve(NVVE.US$ +10.2% (NVVE and CENN announce alliance to offer electrification solution for commercial fleets)
• $ShockWave Medical(SWAV.US$ +14.6% (I...
19
2
ColumnsTop upgrades and downgrades on 5/10
Upgrades
•$Autoliv(ALV.US$ : UBS Upgrades to Buy from Neutral - PT $90 (from $103)
• $Clean Energy Fuels(CLNE.US$ : Raymond James Upgrades to Outperform from Market Perform - PT $6
• $EOG Resources(EOG.US$ : Raymond James Upgrades to Strong Buy from Outperform - PT $170
• $Genuine Parts(GPC.US$ : BofA Securities Upgrades to Neutral from Underperform - PT $133
• $Graphic Packaging(GPK.US$ : Exane Upgrades to Outperform from Neutral - PT $26
• $Healthcare Trust of America Inc(HTA.US$ : Berenbe...
•$Autoliv(ALV.US$ : UBS Upgrades to Buy from Neutral - PT $90 (from $103)
• $Clean Energy Fuels(CLNE.US$ : Raymond James Upgrades to Outperform from Market Perform - PT $6
• $EOG Resources(EOG.US$ : Raymond James Upgrades to Strong Buy from Outperform - PT $170
• $Genuine Parts(GPC.US$ : BofA Securities Upgrades to Neutral from Underperform - PT $133
• $Graphic Packaging(GPK.US$ : Exane Upgrades to Outperform from Neutral - PT $26
• $Healthcare Trust of America Inc(HTA.US$ : Berenbe...
15
2
ColumnsTop upgrades and downgrades on 4/11
Upgrades
• $ChampionX(CHX.US$: Piper Sandler Upgrades to Overweight From Neutral - PT $30 (from $28)
• $CatchMark Timber Trust Inc(CTT.US$: Baird Upgrades to Outperform from Neutral - PT $10 (from $9)
• $EPAM Systems(EPAM.US$: Wolfe Research Upgrades to Outperform from Peerperform - PT $390 (from $550)
• $Essent(ESNT.US$: JPMorgan Upgrades to Overweight from Neutral - PT $47 (from $54)
• $JetBlue Airways(JBLU.US$: MKM Partners Upgrades to Neutral from Sell...
• $ChampionX(CHX.US$: Piper Sandler Upgrades to Overweight From Neutral - PT $30 (from $28)
• $CatchMark Timber Trust Inc(CTT.US$: Baird Upgrades to Outperform from Neutral - PT $10 (from $9)
• $EPAM Systems(EPAM.US$: Wolfe Research Upgrades to Outperform from Peerperform - PT $390 (from $550)
• $Essent(ESNT.US$: JPMorgan Upgrades to Overweight from Neutral - PT $47 (from $54)
• $JetBlue Airways(JBLU.US$: MKM Partners Upgrades to Neutral from Sell...
9
4
2
earn a cup of coffee from this . 
ColumnsTime's most influential companies of 2022: Apple, AMC, BYD and more
This week, TIME released its 2022 list of the TIME100 Most Influential Companies.
Which businesses and corporate leaders are shaping our future? That's the question at the heart of TIME100 Most Influential Companies, an annual list that highlights businesses making an extraordinary impact around the world.
To assemble it, TIME solicits nominations across sectors including health care, entertainment, technology, and more from our...
Which businesses and corporate leaders are shaping our future? That's the question at the heart of TIME100 Most Influential Companies, an annual list that highlights businesses making an extraordinary impact around the world.
To assemble it, TIME solicits nominations across sectors including health care, entertainment, technology, and more from our...
50
10
Read more
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--